• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICALE CIE INC VERSACROSS CONNECT LAAC ACCESS SOLUTION; CATHETER, SEPTOSTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICALE CIE INC VERSACROSS CONNECT LAAC ACCESS SOLUTION; CATHETER, SEPTOSTOMY Back to Search Results
Model Number VXAK0007
Medical Device Problem Codes Thermal Decomposition of Device (1071); Failure to Advance (2524)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/18/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The device has not been received for analysis.Upon receipt and completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.We are unable to provide the complete unique identifier (udi) at the time of the submission of this report, as it was not yet available.If additional details become available, a supplemental report will be submitted.
 
Event or Problem Description
It was reported that versacross connect laac access solution was selected for left atrial appendage closure.During the procedure, the physician attempted to cross the septum with rf wire four different times, but the rf wire was not able to cross and no error code was noted on the generator.Position of the rf wire was also verified; the septum was thin and had a nice contact.Thus, the rf wire was replaced and the procedure was completed successfully.No patient complication were reported.The device is expected to be return for analysis.The rf was applied all four times and the rf wire was 1-3 mm tent prior to the crossing.Additionally, it was also mentioned that pigtail wire looked normal in shape, but the tip of the wire was black.
 
Additional Manufacturer Narrative
The device has been received for analysis.Upon receipt at our post market quality assurance laboratory, the device passed the visual inspection, since no damage was noted to the distal or proximal ends.Tip was charred.Also, the device passed dimensional test for active tip length.Next, the wire passed functional test, for clearance between electrode and heatshrink within specifications.Finally, the device passed dimensional test, as radio frequency was successfully applied to cross tissue (bench test).The reported allegation of failure to cross is not confirmed as the returned device met specifications and successfully crossed sample tissue.The allegation of charring is confirmed based on the returned device.We are unable to provide the complete unique identifier (udi) at the time of the submission of this report, as it was not yet available.If additional details become available, a supplemental report will be submitted.Correction to the initial mdr in block(s) init rptr also sent rep to fda (e4), in section e - initial reporter.
 
Event or Problem Description
It was reported that versacross connect laac access solution was selected for left atrial appendage closure.During the procedure, the physician attempted to cross the septum with rf wire four different times, but the rf wire was not able to cross and no error code was noted on the generator.Position of the rf wire was also verified; the septum was thin and had a nice contact.Thus, the rf wire was replaced and the procedure was completed successfully.No patient complication were reported.The device is expected to be return for analysis.The rf was applied all four times and the rf wire was 1-3 mm tent prior to the crossing.Additionally, it was also mentioned that pigtail wire looked normal in shape, but the tip of the wire was black.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSACROSS CONNECT LAAC ACCESS SOLUTION
Common Device Name
CATHETER, SEPTOSTOMY
Manufacturer (Section D)
BAYLIS MEDICALE CIE INC
5959 trans-canada highway
montreal H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
zona franca la lima
cartgo, 03 30106
CS   30106
Manufacturer Contact
mary crawford
4100 hamline avenue north
dc a330
saint paul, MN 55112
6514400979
MDR Report Key21996801
Report Number2124215-2025-29942
Device Sequence Number8815259
Product Code DXF
UDI-Device Identifier00685447010524
UDI-Public(01)00685447010524
Combination Product (Y/N)N
Initial Reporter StateSD
Initial Reporter CountryUS
PMA/510(K) Number
K150709
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 10/15/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberVXAK0007
Device Catalogue NumberVXAK0007
Device Lot Number0035595058
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/18/2025
Supplement Date Received by Manufacturer09/30/2025
Initial Report FDA Received Date05/09/2025
Supplement Report FDA Received Date10/15/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured11/15/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexFemale
-
-